Three studies were included in evaluating the correlation between the expression of CD24 in CRC and Duke’s stage, including 125 patients with Duke’s stage A&B and 60 patients with Duke’s stage C&D stage (Figure 4). The gene discussed is CD24; the disease is colorectal carcinoma.